| Phase 1 | 2 | |
| Phase 4 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT07369622 | HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-Effectiveness | Gout Initiating Urate-loweringUrate-lowering Therapy | Not Yet Recruiting | 2026-01-27 |
| Phase 1 | ||||
| NCT07032558 | Comparison of DW-1021 and Separate Doses of Pelubi CR and Zytram CR Under Fasting… | Healthy Volunteer | Recruiting | 2025-08-28 |
| NCT07060209 | Food Effect on PK of DW-1021 (Pelubiprofen 45 mg / Tramadol 45.9 mg) in Healthy Adults | Healthy Volunteers | Recruiting | 2025-08-28 |
| Not applicable | ||||
| NCT07153549 | Biolizin for Improving Functional Poor Appetite in Children Aged 6 to 36 Months (CTBE2502) | Feeding and Eating Disorders of Childhood | Recruiting | 2026-01-30 |
| NCT07148583 | BioAmicus Complete for Functional Gastrointestinal Symptoms in Infants Aged 0 to 24 Months | Infantile Colic | Recruiting | 2026-01-29 |
| NCT07643532 | A Single-center, Randomized, Double-blind, Placebo-controlled, Intervention Clinical… | Blood Circulation | Not Yet Recruiting | 2026-06-11 |